Generation and external validation of a histologic transformation risk model for patients with follicular lymphoma

dc.contributor.authorFernández-Miranda, Ismael
dc.contributor.authorEspinet Solà, Blanca
dc.contributor.authorColomo Saperas, Luis Alberto
dc.contributor.authorSalar Silvestre, Antonio
dc.contributor.authorSánchez-Beato, Margarita
dc.date.accessioned2025-07-22T06:48:50Z
dc.date.available2025-07-22T06:48:50Z
dc.date.issued2024
dc.description.abstractFollicular lymphoma (FL) is the most frequent indolent lymphoma. Some patients (10%-15%) experience histologic transformation (HT) to a more aggressive lymphoma, usually diffuse large B-cell lymphoma (DLBCL). This study aimed to validate and improve a genetic risk model to predict HT at diagnosis.We collected mutational data from diagnosis biopsies of 64 FL patients. We combined them with the data from a previously published cohort (total n = 104; 62 from nontransformed and 42 from patients who did transform to DLBCL). This combined cohort was used to develop a nomogram to estimate the risk of HT. Prognostic mutated genes and clinical variables were assessed using Cox regression analysis to generate a risk model. The model was internally validated by bootstrapping and externally validated in an independent cohort. Its performance was evaluated using a concordance index and a calibration curve. The clinicogenetic nomogram included the mutational status of 3 genes (HIST1HE1, KMT2D, and TNFSR14) and high-risk Follicular Lymphoma International Prognostic Index and predicted HT with a concordance index of 0.746. Patients were classified as being at low or high risk of transformation. The probability HT function at 24 months was 0.90 in the low-risk group vs 0.51 in the high-risk group and, at 60 months, 0.71 vs 0.15, respectively. In the external validation cohort, the probability HT function in the low-risk group was 0.86 vs 0.54 in the high-risk group at 24 months, and 0.71 vs 0.32 at 60 months. The concordance index in the external cohort was 0.552. In conclusion, we propose a clinicogenetic risk model to predict FL HT to DLBLC, combining genetic alterations in HIST1H1E, KMT2D, and TNFRSF14 genes and clinical features (Follicular Lymphoma International Prognostic Index) at diagnosis. This model could improve the management of FL patients and allow treatment strategies that would prevent or delay transformation.
dc.format.mimetypeapplication/pdf
dc.identifier.citationFernández-Miranda I, Pedrosa L, González-Rincón J, Espinet B, de la Cruz Vicente F, Climent F, et al. Generation and external validation of a histologic transformation risk model for patients with follicular lymphoma. Mod Pathol. 2024 Jul;37(7):100516. DOI: 10.1016/j.modpat.2024.100516
dc.identifier.doihttp://dx.doi.org/10.1016/j.modpat.2024.100516
dc.identifier.issn0893-3952
dc.identifier.urihttp://hdl.handle.net/10230/70963
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofMod Pathol. 2024 Jul;37(7):100516
dc.rights© 2024 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.keywordFollicular lymphoma
dc.subject.keywordGenomics
dc.subject.keywordHistologic transformation
dc.subject.keywordPredictive model
dc.titleGeneration and external validation of a histologic transformation risk model for patients with follicular lymphoma
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Fernandez_mp_gene.pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format

License

Rights